Stiftung Tierärztliche Hochschule Hannover (TiHo)TiHo eLib
  • Publications
  • A human monoclonal antibody blocking SARS-CoV-2 infection

A human monoclonal antibody blocking SARS-CoV-2 infection

The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.

Preview

Category

Published in:
Nature communications
Vol. 11: 2251 (2020)
Volume:
11: 2251
Date Issued:
2020
DOI:
10.1038/s41467-020-16256-y
Language:
English
Type of Resource:
Text
DDC subject of DNB:
570 Life sciences, biology
DDC subject of DNB:
630 Veterinary medicine & agriculture
Anzeige in:
TiHo bibliography
Anzeige in:
Research publications
Auswertung Publikationsindex:
2020
Link to Raw Object:
https://www.nature.com/articles/s41467-020-16256-y
Hosting institution:
Research Centers, Research Center for Emerging Infections and Zoonoses (RIZ)

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

Use and reproduction:

Export

BibTeX, MODS, MARCXML, RIS, ISI, PICA, CSV, DC